ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Varespladib Infusion in Subjects With Sickle Cell Disease. (IMPACTS-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01522196
Recruitment Status : Terminated (change in company plans)
First Posted : January 31, 2012
Last Update Posted : March 4, 2014
Sponsor:
Information provided by (Responsible Party):
Anthera Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : March 2012
  Actual Study Completion Date : March 2012
  Certification/Extension First Submitted : January 30, 2014